International Journal of Hypertension / 2016 / Article / Tab 4

Research Article

An Analysis of Anthropometric Indicators and Modifiable Lifestyle Parameters Associated with Hypertensive Nephropathy

Table 4

Partial correlation coefficients of haemodynamic parameters, anthropometric variables, and biochemical kidney markers of study population (upper right sided) and indices of hypertension group (lower left sided), adjusted for age and gender.

IndexSBPDBPPulseMAPWCHCBMIWHRWHtRCIAVIBAIK+Na+CLUreaCreatUAMAMDRDCGEPI

SBP.51.20.85.20.16−0.030.04.19.24.18.300.07.23.39.21.150.10−0.09−0.03−0.01−0.06
DBP.39.25.89.19.190.050.000.12.17.16.280.01.35.520.11.130.010.010.000.08−0.02
Pulse0.020.01.26.64.69.170.07.58.57.68.66.22.20.40.220.05.290.01−0.010.11−0.01
MAP.83.830.02.22.200.010.02.18.24.19.310.04.33.53.18.160.06−0.04−0.010.04−0.05
WC0.04−0.07.60−0.02.95.370.1.93.89.99.86.19.14.40.29.21.440.08−.180.03−.20
HC0.02−0.04.66−0.01.94.33−0.12.88.84.96.90.23.13.35.26.21.470.06−.21−0.01−.21
BMI−0.060.01.18−0.03.37.320.03.47−0.03.33.430.020.000.090.010.06−0.030.12−0.11.19−0.10
WHR0.04−0.020.080.010.07−.160.000.100.100.09−0.10−0.040.000.030.07−0.08−0.090.01.17.180.09
WHtR0.07−0.09.55−0.01.93.86.420.07.80.92.95.160.12.33.29.20.430.1−.21−0.04−.22
CI0.10−0.08.510.01.87.81−0.090.08.80.89.75.16.15.37.29.19.490.05−.16−0.1−.18
AVI0.04−0.07.65−0.02.99.96.330.07.92.87.88.210.11.36.29.20.460.07−.180.01−.20
BAI0.05−0.07.60−0.01.86.89.39−0.13.95.73.87.24.25.40.35.27.520.11−.30−.14−.32
K+0.02−0.10.21−0.05.20.240.09−0.05.19.15.22.21.210.11.20.16.19−0.03−.14−0.1−0.11
Na+0.06.160.040.14−0.06−0.04−0.04−0.02−0.040.040.06−0.02.20.35.160.10−0.03−0.020.080.110.02
CL0.120.100.090.130.140.110.040.060.100.12.160.060.030.03.31.18.210.08−0.040.08−0.08
Urea0.09−0.120.08−0.02.20.170.000.09.22.19.21.20.180.040.02.38.29−0.05−.23−.18−.27
Creat0.090.04−0.030.08.17.170.07−0.11.170.14.16.170.150.050.06.36.300.02−.80−.73−.79
UA0.02−0.14.24−0.07.45.46−0.06−0.13.43.49.45.42.18−0.120.11.24.270.02−.29−.27−.27
MA−0.13−0.06−0.04−0.110.020.000.100.040.050.000.020.03−0.04−0.080.09−0.090.030.03−0.05−0.03−0.05
MDRD−0.020.040.010.01−.20−.22−0.130.21−.22−.16−.19−.24−.150.100.00−.23−.81−.29−0.06.92.90
CG−0.050.050.08−0.01−0.06−0.09.150.20−0.12−.19−0.06−.16−0.120.070.04−.23−.77−.29−0.07.94.81
EPI−0.030.050.040.01−.20−.21−0.130.11−.22−.17−.19−.22−0.120.05−0.01−.26−.80−.26−0.06.90.83

SBP: systolic blood pressure, DBP: diastolic blood pressure, MAP: mean arterial pressure, WC: waist circumference, HC: hip circumference, BMI: body mass index, WHR: waist-to-hip ratio, WHtR: waist-to-height ratio, CI: conicity index, AVI: abdominal volume index, K+: potassium, Na+: sodium, CL: chloride, creat: creatinine, UA: uric acid, MA: microalbumin, MDRD: four-variable modification of diet in renal disease, CG: Cockcroft-Gault, and EPI: chronic kidney disease epidemiology collaboration. Correlation is significant at 0.05 and correlation is significant at 0.01.

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.